Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medra Corporation (MDRA)
Valencia, US
Medra Corporation specializes in the acquisition, advancement, and commercialization of hydrogen-based technologies. The company primarily focuses its efforts on fuel cells, hydrogen-specific sensing devices, and solutions for hydrogen safety. Its operational model involves identifying innovative technologies, subsequently securing intellectual property rights through licensing agreements with patent holders, and then developing these into viable products for manufacturing and sale. The company offers a range of hydrogen sensors, available as portable, handheld units or stationary devices designed for wall, ceiling, or conduit mounting, catering to diverse industries and clientele. Additionally, Medra develops, produces, and markets fuel cells with power outputs spanning from 12 watts to 5 kilowatts. Its H2SCAN hydrogen-specific sensing systems present an enhanced alternative to traditional gas detectors, finding applications in sectors such as food processing, petrochemical production, semiconductor manufacturing, and the glass and metals industries. Medra Corporation possesses licenses for critical technologies, including The Robust Hydrogen Sensor, The Thick Film Hydrogen Sensor, and The Proton Exchange Membrane Fuel Cell. Founded in 1994, the company is headquartered in Valencia, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +2,054,900.00% | +20,450.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+18.9% ★ Q2'02: -16.9% (vs Q2'01)
-
EPS growth Chemicals - Specialty: +13.2%+3.1% Q2'02: +37.5% (vs Q2'01)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-919.2% Q2'02: -377.9% (vs Q2'01)
-
EBIT margin Chemicals - Specialty: +8.8%-867.0% Q2'02: -1,004.2% (vs Q2'01)
-
ROIC Chemicals - Specialty: +5.6%-811.8%
-
Share dilution Chemicals - Specialty: +0.1%+32.5% Q2'02: +25.1% (vs Q2'01)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× Q2'02: 0.00× (vs Q2'01)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Johan Friedericy | Chief Operating Officer, Vice President and Director | 57.7K | — |
| John T. Donohue | Vice Chairman of the Board, Chief Executive Officer and President | — | male |
| Ronald L. Ilsley | Chief Financial Officer, Principal Accounting Officer and Vice President - Finance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MDRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
